Ординатура / Офтальмология / Английские материалы / Antigen Presenting Cells and the Eye_Zierhut, Rammensee, Streilein_2007

[T cell] LCS, 80

MHC molecules, 17

MHC peptide complexes, 37 proliferation, 42

Pseudomonas aeruginosa, 172 regulatory types, 42

T cell receptor (TCR) genes, 192 ovalbumin, 132

TALT. See Tear duct-associated lymphoid tissue (TALT)

TAP. See Transporter antigen processing (TAP)

TARC. See Thymus activation regulated chemokine (TARC)

Tear duct-associated lymphoid tissue (TALT), 84

dry eye, 88

TGN. See Trans-Golgi network (TGN)

Thrombospondin (TSP), 124–125 APC, 127

extracellular matrix protein, 125 Thymic-stromal lymphopoetin

(TSLP) keratinocytes, 184

Thymus activation regulated chemokine (TARC), 106

keratinocytes, 184

TLR. See Toll-like receptors (TLR) TNF. See Tumor necrosis factor (TNF) Tolerogenic antigen presenting cell, 22 Toll-like receptors (TLR), 170

DC, 15

future, 176–177

Pseudomonas aeruginosa keratitis, 173–174

Toxoplasma

IL-12, 175 Trabecular cells

outflow pathways, 58–59 phagocytic properties, 58 Trabecular meshwork (MW), 58 Trans-Golgi network (TGN), 96

immature secretory vesicles, 97 transport vesicles, 96

Transcytosis, 96

Transepidermal water loss, 183 Transporter antigen processing

(TAP), 10

TRP. See Tyrosinase-related protein 1 TSLP. See Thymic-stromal lymphopoetin

(TSLP)

TSP. See Thrombospondin (TSP) Tumor necrosis factor (TNF)

CsA, 138

Tumor necrosis factor-alpha (TNF-alpha), 152

keratinocytes, 184

retinal pigment epithelial cells, 195 Tyrosinase-related protein 1, 201 Tyrosinase-related protein 2, 41

Ultraviolet (UV) irradiation donor LC, 161

Uveal melanoma HLA-A, 218–219 HLA-B, 218–219

intraocular tumor, 220–221 irradiated macrophages, 222 lymphocytes, 219

macrophages, 217–223, 219–220 determination, 221

tumor immunology, 220–221 metastatic, 223

NK cells, 219

prognostic factors, 218–219

systemic immunization animal model, 220–221

Uveal tract DC, 56–58

immune responses, 53–58 Uveitis

antigen specificity, 194 APC, 189–195 endogenous posterior, 190

vitreous cells, 193 immune processes, 192

immune responses regulation, 193–194 vitreous T cells, 194

Uveoretinitis

experimental autoimmune, 190

Vascular cell adhesion molecule-1 (VCAM-1), 222

Vascular endothelial growth factor receptor (VEGFR), 153

Vasoactive intestinal peptide (VIP), 99 cornea, 172–173

VCAM-1. See Vascular cell adhesion molecule-1 (VCAM-1)

VEGFR. See Vascular endothelial growth factor receptor (VEGFR)

Veiled cells, 31

VIP. See Vasoactive intestinal peptide (VIP)

Xerosis, 183